Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine

Clinical Infectious Diseases

Volumn 59, Issue 5, 2014, Pages 615-623

  Pelton, Stephen I ^a,b   Weycker, Derek ^c   Farkouh, Raymond A ^d   Strutton, David R ^d   Shea, Kimberly M ^a   Edelsberg, John ^c  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c POLICY ANALYSIS INC PAI   (United States)

^d PFIZER INC   (United States)

Author keywords

Comorbidity; Pneumococcal infections; Pneumonia; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHRONIC DISEASE; DISEASE SEVERITY; HIGH RISK PATIENT; HUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; COHORT ANALYSIS; COMPLICATION; FEMALE; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; RETROSPECTIVE STUDY; RISK;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; RISK; VACCINES, CONJUGATE;

EID: 84907398017     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu348     Document Type: Article

References (17)

1. Babl FE, Pelton SI, Theodore S, Klein JO. Consistency of distribution of serogroups of invasive pneumococcal isolates among children: experience during 4 decades. Clin Infect Dis 2001; 32:1155-61. (Pubitemid 32381121)
2. van Hoek AJ, Andrews N, Waight PA, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England. J Infect 2012; 65:17-24.
3. Ladhani SN, Slack MP, Andrews NJ, Waight PA, Borrow R, Miller E. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis 2013; 19:61-8.
4. Hjuler T, Wohlfahrt J, Staum Kaltoft M, Koch A, Biggar RJ, Melbye M. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008; 122:e26-32.
5. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000; 49: 1-35.
6. Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59: 1-18.
7. Pickering L, ed. Report of the Committee on Infectious Diseases. 29th ed. American Academy of Pediatrics, 573, table 3.46.
8. Public Health England. Pneumococcal: The Green Book, chapter 25. Pneumococcal meningitis notifiable. Available at: https://www.gov.uk/government/ uploads/system/uploads/attachment-data/file/216088/Green-Book-Chapter-25-v4-0. pdf. Accessed 4 July 2013.
9. Centers for Disease Control and Prevention (CDC). Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010; 59:1102-6.
10. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 961-6.
11. Yildirim I, Stevenson A, Hsu KK, Pelton SI. Evolving picture of invasive pneumococcal disease in Massachusetts children: a comparison of disease in 2007-2009 with earlier periods. Pediatr Infect Dis J 2012; 31:1016-21.
12. Kaplan SL, Barson WJ, Lin PL, et al. Serotype 19A is the most common serotype causing invasive pneumococcal disease in children. Pediatrics 2010; 125:429-36.
13. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 2010; 201:32-41.
14. Yildirim I, Hanage WP, Lipsitch M, et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010; 29:283-8.
15. Centers for Disease Control and Prevention (CDC). Active Bacterial Core surveillance report, Emerging Infections Program network: Streptococcus pneumoniae, 2007. Available at: http://www.cdc.gov/abcs/reports-findings/ survreports/spneu07.pdf. Accessed 26 June 2013.
16. Grijalva CG, Griffin MR. Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Expert Rev Vaccines 2008; 7:83-95. (Pubitemid 351359055)
17. Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG; Active Bacterial Core surveillance team. Invasive pneumococcal infections among vaccinated children in the United States. J Pediatr 2010; 156:478-83.e2.